Connect with us

Hi, what are you looking for?

Life

China makes use of AI for healthcare

One reason for the focus on lung cancer is because China has one of the highest lung cancer rates in the world. According to Time Magazine, Chines medics predict that over 800,000 annual diagnoses and 700,000 annual deaths can be expected by 2020.

An estimated 300 million Chinese people are smokers. China has also a serious issue with hazardous air pollution. Here concentrations of small, breathable particles (PM2.5) invariably exceeding 300 micrograms per cubic meter in the industrialized northern regions.

Moreover, Forbes has reported there are 80,000 radiologists employed in China, and most of the day-to-day activities of these healthcare professionals, is with the diagnosis of lung cancer. These radiologists examine some 1.4 billion radiology scans a year.

This level of ‘at risk’ cases makes the interpretation of lung images a priority. A tool to help with this is artificial intelligence connected to scanners. One area where this is being tested out is at the Shanghai Changzheng Hospital in China.

At the hospital radiologists have been operating an artificial intelligence technology produced by Infervison. The technology aims to improve medical diagnosis from the processing of computed tomography scans and X-rays. Again according to Forbes, the technology can identify suspicious lesions and nodules in lung cancer patients.

Infervison works with a number of other major medical technology firms, such as GE Healthcare, Cisco, and Nvidia. The system is being tested out in over twenty tertiary grade A hospitals in China. Infervision installs its software on-premise at hospitals and updates its image recognition and diagnostics tools based on the data coming in from its training hospitals.

The technology works by linking a computerized tomography scan with a type of artificial intelligence that can learn the core characteristics of lung cancer and then detect the suspected cancer features through various mage sequences. The aim is to enable medics to issue treatments more quickly based on a more accurate and earlier diagnosis.

In a recent statement, Chen Kuan, founder and CEO of Infervision outlined the mission values: “Our goal at Infervision is to build a stronger medical industry and help accelerate diagnoses which is so important for patient.”

Written By

Dr. Tim Sandle is Digital Journal's Editor-at-Large for science news. Tim specializes in science, technology, environmental, and health journalism. He is additionally a practising microbiologist; and an author. He is also interested in history, politics and current affairs.

You may also like:

World

France's parliament voted to make vaccine passports a key part of daily life in the battle against Covid-19.

Business

Streaming services and record labels can no longer justify paying artists derisory sums. Time for change has come.

World

Buses and cars were left stranded when roads across London flooded on Sunday, as repeated thunderstorms battered the British capital.

World

Nearly 200 nations start online negotiations Monday to validate a UN science report.